Last reviewed · How we verify
NCT06093815
Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products
NA trial testing Injection in Injection Site Reaction in 20 participants. Completed in 1 November 2024.
1 May 2024
Quick facts
| Lead sponsor | Merz North America, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 8 September 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Injection
Conditions studied
- Injection Site Reaction — all drugs for Injection Site Reaction →
Sponsor
Merz North America, Inc. — full company profile →
Who can join
Adults 22 to 65, any sex, with Injection Site Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to identify and assess in vivo tissue responses after injection with various biostimulatory products at various timepoints. The study will also provide tissue specimens which will be used in a subsequent study. Safety endpoint: incidence of adverse events.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06093815
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Injection
Trials testing the same drug.
- NCT07509164 — The Effect of a Multimodal Approach on Pain, Fear, and Anxiety in Injection Experiences in Children · NA · completed
- NCT07010900 — Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's · NA · recruiting
- NCT06729840 — Intralesional Treatment of Keloids · Phase 3 · recruiting
- NCT06653244 — Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy · Phase 1 · completed
- NCT05531500 — Patient Reported Outcomes Following Interventional Procedures in Pelvic Pain · NA · unknown
Other Merz North America, Inc. trials
Trials by the same sponsor.
- NCT05222607 — Longitudinal Evaluation and Real-world Evidence of NT201 · terminated
- NCT05784363 — A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face · Phase 1 · completed
- NCT05163353 — Evaluation of the Effectiveness and Safety of Diluted RADIESSE® in the Treatment of Décolleté Wrinkles · NA · completed
- NCT04886232 — A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effect · NA · completed
- NCT05067504 — Effectiveness and Safety of the Octave System for Lifting the Eyebrow and Improving the Appearance of the Face and Neck · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06093815 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Merz North America, Inc.
- Last refreshed: 13 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093815.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing